Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003
Clinical trial NCT04970914 · UNKNOWN
Trial details
- NCT number
- NCT04970914
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2022-08-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.